[1]
Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet journal of rare diseases. 2008 Sep 16:3():24. doi: 10.1186/1750-1172-3-24. Epub 2008 Sep 16
[PubMed PMID: 18796143]
[2]
Braunlin E, Steinberger J, DeFor T, Orchard P, Kelly AS. Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Jun:24(6):1289-1293. doi: 10.1016/j.bbmt.2018.01.028. Epub 2018 Feb 1
[PubMed PMID: 29409846]
[3]
Horovitz DD, Magalhães Tde S, Pena e Costa A, Carelli LE, Souza e Silva D, de Linhares e Riello AP, Llerena JC Jr. Spinal cord compression in young children with type VI mucopolysaccharidosis. Molecular genetics and metabolism. 2011 Nov:104(3):295-300. doi: 10.1016/j.ymgme.2011.07.019. Epub 2011 Jul 23
[PubMed PMID: 21813307]
[4]
Harrison R, Schaefer S, Warner L, Mercer J, Jones S, Bruce I. Transnasal adenoidectomy in mucopolysaccharidosis. International journal of pediatric otorhinolaryngology. 2018 Aug:111():149-152. doi: 10.1016/j.ijporl.2018.04.028. Epub 2018 May 1
[PubMed PMID: 29958599]
[5]
Mesolella M, Cimmino M, Cantone E, Marino A, Cozzolino M, Della Casa R, Parenti G, Iengo M. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale. 2013 Aug:33(4):267-72
[PubMed PMID: 24043915]
[6]
Ruckenstein MJ, Macdonald RE, Clarke JT, Forte V. The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review. The Journal of otolaryngology. 1991 Jun:20(3):177-83
[PubMed PMID: 1908026]
Level 2 (mid-level) evidence
[7]
Fensom AH, Benson PF. Recent advances in the prenatal diagnosis of the mucopolysaccharidoses. Prenatal diagnosis. 1994 Jan:14(1):1-12
[PubMed PMID: 8183831]
Level 3 (low-level) evidence
[8]
Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (London, England). 1981 Oct 3:2(8249):709-12
[PubMed PMID: 6116856]
[9]
Ponder KP, Haskins ME. Gene therapy for mucopolysaccharidosis. Expert opinion on biological therapy. 2007 Sep:7(9):1333-45
[PubMed PMID: 17727324]
Level 3 (low-level) evidence